R15L (p.Arg15Leu) variant of KRT6A (Keratin, type II cytoskeletal 6A)

R15L (p.Arg15Leu) in KRT6A (Keratin, type II cytoskeletal 6A) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.11 / 1. The record also includes population frequency data and structural context.

R15L (p.Arg15Leu) variant details